📰 Abt News
Page 29 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
February 8, 2024
Arcblock (ABT) traded 9.7% lower against the US dollar during the 1 day period ending at 22:00 PM ET on February 7th. Arcblock has a total market capitalization of $101.45 million and $9.41 million worth of Arcblock was traded on exchanges in the last 24 hours. Over the last week, Arcblock has traded 196.1% higher […]
February 8, 2024
Financial Security Advisor Inc. acquired a new stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 3,732 shares of the healthcare product maker’s stock, valued at approximately $361,000. A number of other large investors […]
February 8, 2024
New Delhi, Feb 8 (PTI) Delay in the provisioning of Availability Based Tariff (ABT) Metres by the West Central Railway resulted in an additional expenditure of Rs 75.10 crore on power purchase, according to a Public Accounts Committee (PAC) report.
February 8, 2024
Herold Advisors Inc. lifted its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 65.1% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 20,450 shares of the healthcare product maker’s stock after purchasing an additional 8,062 shares during the period. Herold Advisors Inc.’s holdings […]
February 8, 2024
Milestone Resources Group Ltd lessened its position in Abbott Laboratories (NYSE:ABT – Free Report) by 0.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 894,137 shares of the healthcare product maker’s stock after selling 1,992 shares during the period. Abbott Laboratories […]
February 7, 2024
McCollum Christoferson Group LLC trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 75,318 shares of the healthcare product maker’s stock after selling 1,359 shares during the period. Abbott Laboratories […]
February 7, 2024
Pathstone Family Office LLC raised its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 223.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 143,541 shares of the healthcare product maker’s stock after purchasing an additional 99,144 shares during the […]
February 7, 2024
Obermeyer Wood Investment Counsel Lllp lifted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 1.2% in the 3rd quarter, Holdings Channel.com reports. The fund owned 14,558 shares of the healthcare product maker’s stock after acquiring an additional 173 shares during the period. Obermeyer Wood Investment Counsel Lllp’s holdings in Abbott Laboratories were worth […]
February 7, 2024
Beverly Hills Private Wealth LLC lessened its position in Abbott Laboratories (NYSE:ABT – Free Report) by 43.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,506 shares of the healthcare product maker’s stock after selling 13,597 shares during […]
February 6, 2024
Spire Wealth Management lowered its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 8.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 29,425 shares of the healthcare product maker’s stock after selling 2,728 shares during the […]